Nanomaterial genotoxicity evaluation using the high-throughput p53-binding protein 1 (53BP1) assay
PLOS ONE · 15.09.2023 · 18 (9) · e0288737
DOI: 10.1371/journal.pone.0288737 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 15.09.2023. Verfasst von Maelle Fontaine und 13 weiteren Autor:innen. Beteiligte Einrichtung: CEA, CNRS, IRIG, SyMMES-CIBEST, Univ. Grenoble Alpes, Grenoble, France. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Nanostructures. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union’s Horizon 2020 research and innovation programme, French Government’s Investissements d’Avenir program of Agence Nationale de la Recherche, LabEx SERENADE.
Abstract (Originalsprache)
Toxicity evaluation of engineered nanomaterials is challenging due to the ever increasing number of materials and because nanomaterials (NMs) frequently interfere with commonly used assays. Hence, there is a need for robust, high-throughput assays with which to assess their hazard potential. The present study aimed at evaluating the applicability of a genotoxicity assay based on the immunostaining and foci counting of the DNA repair protein 53BP1 (p53-binding protein 1), in a high-throughput format, for NM genotoxicity assessment. For benchmarking purposes, we first applied the assay to a set of eight known genotoxic agents, as well as X-ray irradiation (1 Gy). Then, a panel of NMs and nanobiomaterials (NBMs) was evaluated with respect to their impact on cell viability and genotoxicity, and to their potential to induce reactive oxygen species (ROS) production. The genotoxicity recorded using the 53BP1 assay was confirmed using the micronucleus assay, also scored via automated (high-throughput) microscopy. The 53BP1 assay successfully identified genotoxic compounds on the HCT116 human intestinal cell line. None of the tested NMs showed any genotoxicity using the 53BP1 assay, except the positive control consisting in (CoO)(NiO) NMs, while only TiO 2 NMs showed positive outcome in the micronucleus assay. Only Fe 3 O 4 NMs caused significant elevation of ROS, not correlated to DNA damage. Therefore, owing to its adequate predictivity of the genotoxicity of most of the tested benchmark substance and its ease of implementation in a high throughput format, the 53BP1 assay could be proposed as a complementary high-throughput screening genotoxicity assay, in the context of the development of New Approach Methodologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- CEA, CNRS, IRIG, SyMMES-CIBEST, Univ. Grenoble Alpes, Grenoble, France.
- National Research Council, Institute of Science, Technology and Sustainability for Ceramic Materials ISSMC-CNR (Former ISTEC-CNR), Faenza, Italy.
- Ce.Ri.Col, Colorobbia Consulting S.R.L, Sovigliana-Vinci, Firenze, Italy.
- Department of Chemistry, University of Turin, Turin, Italy.
- Institute of Occupational Medicine, Edinburgh, Midlothian, United Kingdom.
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Förderung
- European Union’s Horizon 2020 research and innovation programme
- French Government’s Investissements d’Avenir program of Agence Nationale de la Recherche
- LabEx SERENADE
Zitieren
APA
Fontaine, M., Bartolami, E., Prono, M., Béal, D., Blosi, M., Costa, A. L., Ravagli, C., Baldi, G., Sprio, S., Tampieri, A., Fenoglio, I., Tran, L., Fadeel, B., & Carriere, M. (2023). Nanomaterial genotoxicity evaluation using the high-throughput p53-binding protein 1 (53BP1) assay. PLOS ONE, 18(9), e0288737. https://doi.org/10.1371/journal.pone.0288737
Vancouver
Fontaine M, Bartolami E, Prono M, Béal D, Blosi M, Costa AL, et al. Nanomaterial genotoxicity evaluation using the high-throughput p53-binding protein 1 (53BP1) assay. PLOS ONE. 2023;18(9):e0288737. doi:10.1371/journal.pone.0288737
BibTeX
@article{Fontaine2023,
author = {Fontaine, Maelle and Bartolami, Eline and Prono, Marion and Béal, David and Blosi, Magda and Costa, Anna L and Ravagli, Costanza and Baldi, Giovanni and Sprio, Simone and Tampieri, Anna and Fenoglio, Ivana and Tran, Lang and Fadeel, Bengt and Carriere, Marie},
title = {Nanomaterial genotoxicity evaluation using the high-throughput p53-binding protein 1 (53BP1) assay},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {9},
pages = {e0288737},
doi = {10.1371/journal.pone.0288737}
}
EUVIMED